发明名称 FINAL GLYCATE-FORMATION INHIBITOR
摘要 PROBLEM TO BE SOLVED: To provide a final glycate-formation inhibitor easy for appropriately performing the physiology in hypertension. SOLUTION: A final glycate-formation inhibitor contains a water-extract of tanjin, a water-extract of peony root, a water-extract of cyperus rhizome or kangen granule as an effective component. This final glycate-formation inhibitor restrains formation of final glycate (AGEs) which is promoted in hypertension, alteration of superoxide dismutase (SOD), formation of active oxygen (O<SB>2</SB><SP>-</SP>) and increase of lipid peroxides, and also restrains polyol route which is activated in hypertension. As a result, it appropriately performs the physiology in hypertension and restrains start and development of the complication of diabetes. The kangen granule is prepared with a specific ratio of each constituting herbal medicines; tanjin, cyperus rhizome, saussurea root, bastard saffron, peony root and cnidium rhizome (for example, 4:1:1:2:2:2 in weight ratio). COPYRIGHT: (C)2010,JPO&INPIT
申请公布号 JP2010180250(A) 申请公布日期 2010.08.19
申请号 JP20100120332 申请日期 2010.05.26
申请人 ISKRA IND CO LTD 发明人 YOKOZAWA TAKAKO;SATO AKIKO;SEI YASUO;OKAMOTO TAKUYA
分类号 A61K36/18;A61K36/00;A61K36/53;A61P3/10;A61P43/00 主分类号 A61K36/18
代理机构 代理人
主权项
地址